Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery



      The polyphenolic compound resveratrol presented in red wine has potent cardiovascular effect in animal. Here, we investigated the ability of resveratrol to relax human coronary bypass grafts, saphenous vein and internal mammary artery and also its effect on their endothelial reactivity.


      Vascular rings were obtained from 38 male patients undergoing coronary artery bypass operation. The relaxant effects of resveratrol (10–70 μM) and acetylcholine (10−8–10−4 M) were examined on precontracted saphenous vein and internal mammary artery rings.


      Resveratrol, at concentration of 70 μM caused relaxations of 34.2±5.7% in saphenous vein and 35.2±5.4% in internal mammary artery. Endothelium removal and l-NOARG (nitric oxide synthase inhibitor, 10−4 M) pretreatment almost completely inhibited the relaxation to resveratrol in internal mammary artery but partially in saphenous vein rings. Indomethacin (cyclooxygenase inhibitor, 10−5 M) slightly, but not significantly enhanced the relaxation to resveratrol in both vessels. The endothelium-dependent relaxations to acetylcholine were significantly improved in the presence of resveratrol of 20 μM in both grafts (Emax: 33.8±3.7% versus 46.8±4% in saphenous vein n=9; p<0.05; 54. 4±5.3% versus 69.3±5.4% in internal mammary artery, n=8, p<0.05). The relaxations to acetylcholine were fully eliminated by combination of resveratrol with l-NOARG (10−4 M) in both vessels.


      Resveratrol produced mainly endothelium-dependent and nitric oxide-mediated vasodilation in human internal mammary artery but partially in saphenous vein rings and improved their endothelial reactivity. This may have a therapeutic potential in cardiovascular diseases.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Napoli C.
        • Ignarro I.J.
        Nitric oxide and atherosclerosis.
        Nitric Oxide. 2001; 5: 88-97
        • Luscher T.F.
        • Noll G.
        The pathogenesis of cardiovascular disease: role of the endothelium as target and mediator.
        Atherosclerosis. 1995; 188: S81-S90
        • Lytle B.W.
        • Loop F.D.
        • Cosgrove D.M.
        Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass graft.
        J Thorac Cardiovasc Surg. 1985; 89: 248-258
        • Rosenfeldt F.L.
        • Guo-Wie H.
        • Buxton B.F.
        • Angus J.A.
        Pharmacology of coronary artery bypass grafts.
        Ann Thorac Surg. 1999; 67: 878-888
        • Chaikhouini A.
        • Crawford F.A.
        • Kochel P.J.
        • Olanoff L.S.
        • Halushka P.V.
        Human internal mammary artery produces more prostacyclin than saphenous vein.
        J Thorac Cardiovasc Surg. 1986; 92: 88-91
        • Luscher T.F.
        • Diederich D.
        • Siebenmann R.
        • Lehmann K.
        • Stulz P.
        • von Segesser L.
        • et al.
        Difference between endothelium-dependent relaxation in arterial and venous coronary bypass grafts.
        N Engl J Med. 1988; 319: 462-467
        • Akar F.
        • Uydes B.S.
        • Ayrancioglu K.
        • Yener A.
        • Aslamaci S.
        • Arsan M.
        • et al.
        Endothelial function of human gastroepiploic artery in comparison with saphenous vein.
        Cardiovasc Res. 1994; 28: 500-504
        • Renaud S.
        • de Lorgeril M.
        Wine alcohol, platelet and the French paradox for coronary heart disease.
        Lancet. 1992; 339: 1523-1526
        • German J.B.
        • Walzem R.L.
        The health benefits of wine.
        Annu Rev Nutr. 2000; 20: 561-593
        • Fitzpatrick D.
        • Hircchfield S.L.
        • Coffey R.G.
        Endothelium-dependent vasorelaxing activity of wine and other grape products.
        Am J Physiol. 1993; 265: H774-H778
        • Andriambeloson E.
        • Kleschyov A.L.
        • Muller B.
        • Beretz A.
        • Stoclet J.C.
        • Andriantsitohaina R.
        • et al.
        Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenolics in rat aorta.
        Br J Pharmacol. 1997; 120: 1053-1058
        • Flesh M.
        • Schwarz A.
        • Böhm M.
        Effect of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries.
        Am J Physiol. 1998; 275: H1183-H1190
        • Leikert J.F.
        • Rathel T.R.
        • Wohlfart P.
        • Cheynier V.
        • Vollmar A.M.
        • Dirsch V.M.
        • et al.
        Red wine polyphenols enhance endothelial nitric oxide release from endothelial cells.
        Circulation. 2002; 106: 1614-1617
        • Demrow H.S.
        • Slane P.R.
        Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries.
        Circulation. 1995; 91: 1182-1188
        • Frankel E.N.
        • Kanner J.
        • Kinsella J.E.
        • German J.B.
        • Parks E.
        • Kinsella J.E.
        Inhibition of oxidation of human low-density lipoprotein with red wine.
        Lancet. 1993; 341: 454-457
        • Chen C.K.
        • Pace-Asciak C.R.
        Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta.
        Gen Pharmacol. 1996; 27: 336-363
        • Wallerath T.
        • Deckert G.
        • Ternes T.
        • Anderson H.
        • Li H.
        • Wine K.
        • et al.
        Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.
        Circulation. 2002; 106: 1652-1658
        • Pace-Asciak C.R.
        • Hahn S.E.
        • Diamandis E.P.
        • Soleas G.
        • Goldberg D.M.
        The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implication for protection against coronary heart disease.
        Clin Chim Acta. 1995; 235: 207-219
        • Rotondo S.
        • Rajtar G.
        • Manarinis S.
        Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function.
        Br J Pharmacol. 1998; 123: 1691-1699
        • Frankel E.N.
        • Waterhouse A.L.
        • Kinsella J.E.
        Inhibition of human DL oxidation by resveratrol.
        Lancet. 1993; 341: 1103-1104
        • Jager U.
        • Nguyen-Doung H.
        Relaxant effect of trans-resveratrol on isolated porcine coronary arteries.
        Arzneim-Forsch. 1999; 49: 207-211
        • Naderali E.K.
        • Smith S.L.
        • Doyle P.J.
        • Williams G.
        The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats.
        Clin Sci. 2001; 100: 55-60
        • Naderali E.K.
        • Doyle P.J.
        • Williams G.
        Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs.
        Clin Sci. 2000; 98: 537-543
        • Orallo F.
        • Alvarez E.
        • Camina M.
        • Leiro J.M.
        • Gomez E.
        • Fernandez P.
        The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption.
        Mol Pharmacol. 2002; 61: 294-302
        • Hamilton C.A.
        • Brosnan M.J.
        • Al-Benna S.
        • Berg G.
        Dominiczak AF NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels.
        Hypertension. 2002; 40: 755-762
        • Kiziltepe U.
        • Turan N.D.
        • Han H.
        • Ulus A.T.
        • Akar F.
        Resveratrol, a red wine polyphenol, protects spinal cord from ischemia–reperfusion injury.
        J Vasc Surg. 2004; 40: 138-145
        • El-Mowafy A.M.
        Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: a novel signalling mechanism in support of coronary protection.
        Biochem Biophys Res Commun. 2002; 291: 1218-1224
        • Jang M.S.
        • Cai L.
        • Udeani G.O.
        • Slowing K.V.
        • Thomas C.F.
        • Beecher C.W.W.
        • et al.
        Cancer chemopreventive activity of resveratrol a natural product derived from grapes.
        Science. 1997; 275: 218-220
        • Hsieh T.C.
        • Juan G.
        • Darzynkiewicz Z.
        • Wu J.M.
        Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21WAF1/CIP1 and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2.
        Cancer Res. 1999; 59: 2596-2601
        • Verma S.
        • Lovren F.
        • Dumont A.S.
        • Mather K.J.
        • Maitland A.
        • Keiser T.M.
        • et al.
        Tetrahydrobiopterin improves endothelial function in human saphenous veins.
        J Thorac Cardiovasc Surg. 2000; 120: 668-671
        • Verma S.
        • Lovren F.
        • Dumont A.S.
        • Mather K.J.
        • Maitland A.
        • Keiser T.M.
        • et al.
        Endothelin receptor blockade improves endothelial function in human internal mammary artery.
        Cardiovasc Res. 2001; 49: 146-151
        • Ko L.
        • Maitland A.
        • Fedak P.M.W.
        • Dumont A.S.
        • Badwala M.
        • Lovren F.
        • et al.
        Endothelin blockade potentiates endothelial protective effects of ACE inhibitors in saphenous veins.
        Ann Thorac Surg. 2002; 73: 1185-1188
        • Bertelli A.
        • Bertelli A.A.
        • Gozzini A.
        • Giovannini L.
        Plasma and tissue resveratrol concentrations and pharmacological activity.
        Drugs Exp Clin Res. 1998; 24: 133-138
        • Bertelli A.A.E.
        • Giovannini L.
        • Stradi R.
        • Urein S.
        • Tillement J.P.
        • Bertelli A.
        • et al.
        Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats.
        Drugs Exp Clin Res. 1998; 24: 51-55
        • Goldberg D.M.
        • Yan J.
        • Soleas G.J.
        Absorption of three wine-related polyphenols in three different matrices by healthy subjects.
        Clin Biochem. 2003; 36: 79-87